XTL Completed the Acquisition of Psyga Bio Ltd.

expands its IP portfolio to clinical-stage biopharmaceutical assets

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.